Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?

Oncotarget - 15 Sept 2015

Brunetti Oronzo, Russo Antonio, Scarpa Aldo, Santini Daniele, Reni Michele, Bittoni Alessandro, Azzariti Amalia, Aprile Giuseppe, Delcuratolo Sabina, Signorile Michele, Gnoni Antonio, Palermo Loredana, Lorusso Vito, Cascinu Stefano, Silvestris Nicola

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) is a tumor with a poor prognosis, short overall survival and few chemotherapeutic choices. MicroRNAs (miRNAs) are non-coding, single-stranded RNAs of around 22 nucleotides involved in the pathogenic mechanisms of carcinogenesis and metastasis. They have been studied in many tumors in order to identify potential diagnostic, prognostic or therapeutic targets. In the current...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Gene Expression Regulation, Neoplastic

Share to Mice, Nude

Share to MicroRNAs

Share to Pancreatic Neoplasms

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 26259238
DOI: 10.18632/oncotarget.4492
PMCID: PMC4695121

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?PMID 26259238Read ↗

Clinical Potential of MicroRNAs in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

miRNAs in pancreatic cancer progression and metastasisSemantic proximity Read ↗

Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic CancerSemantic proximity Read ↗

Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic CancerSemantic proximity Read ↗

Pancreatic biomarkers: could they be the answer?Semantic proximity Read ↗

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and PrognosisSemantic proximity Read ↗

Dysregulation of key microRNAs in pancreatic cancer developmentSemantic proximity Read ↗

The complex network of miRNA and mRNA target interactions in pancreatic cancerSemantic proximity Read ↗

A Review on the Role of MicroRNA in Biology, Diagnosis, and Treatment of Pancreatic AdenocarcinomaSemantic proximity Read ↗

Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomySemantic proximity Read ↗

MicroRNA in Pancreatic Cancer: From Biology to Therapeutic PotentialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.